ENTBF — Entheon Biomedical Share Price
0.000.00%
Last trade - 00:00- $1.01m
- $0.73m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.56 | ||
| Price to Tang. Book | 3.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -90.83% | ||
| Return on Equity | -110.98% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Nov | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 0.02 | 0.19 | 0.25 | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Entheon Biomedical Corp. is a biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Directors
- Last Annual
- November 30th, 2024
- Last Interim
- August 31st, 2025
- Incorporated
- April 6th, 2010
- Public Since
- May 3rd, 2018
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 13,858,934
- Address
- Suite 720-999 W Broadway Street, VANCOUVER, V5Z 1K5
- Web
- https://entheonbiomedical.com/
- Phone
- +1 6045623932
- Contact
- Joseph Cullen
- Auditors
- Manning Elliott LLP
Upcoming Events for ENTBF
Q1 2026 Entheon Biomedical Corp Earnings Release
Q2 2026 Entheon Biomedical Corp Earnings Release
Similar to ENTBF
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
What is the Entheon Biomedical share price?
As of Today at 19:29 UTC, shares in Entheon Biomedical are trading at $0.08. This share price information is delayed by 15 minutes.
How has the Entheon Biomedical share price performed this year?
Shares in Entheon Biomedical last closed at $0.08 and the price had moved by -29.42% over the past 365 days. In terms of relative price strength the Entheon Biomedical share price has underperformed the S&P500 Index by -40.38% over the past year.
What are the analyst and broker recommendations for Entheon Biomedical?
There is no consensus recommendation for this security.
Find out moreWhat is the Entheon Biomedical dividend yield?
Entheon Biomedical does not currently pay a dividend.
Does Entheon Biomedical pay a dividend?
Entheon Biomedical does not currently pay a dividend.
When does Entheon Biomedical next pay dividends?
Entheon Biomedical does not currently pay a dividend.
How do I buy Entheon Biomedical shares?
To buy shares in Entheon Biomedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Entheon Biomedical?
As of the previous close price of $0.08, shares in Entheon Biomedical had a market capitalisation of $1.01m.
Where are Entheon Biomedical shares listed?
Here are the trading details for Entheon Biomedical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ENTBF
What kind of share is Entheon Biomedical?
Based on an overall assessment of its quality, value and momentum Entheon Biomedical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Entheon Biomedical share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Entheon Biomedical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Entheon Biomedical. Over the past six months, its share price has outperformed the S&P500 Index by +6.51%.
As of the last closing price of $0.08, shares in Entheon Biomedical were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Entheon Biomedical PE Ratio?
The Entheon Biomedical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Entheon Biomedical?
We do not have data on Entheon Biomedical's directors